MRK · News · 20260902N

Guidance and Outlook

Merck & Co., Inc. · 2026-09-02 · Importance 32 · Surprise 24

Merck reaffirmed its fiscal 2026 EPS guidance, according to third-party reporting. Analysts cited quarterly revenue of $16.61 billion, up 5.1% year over year, as supporting the outlook. The company is scheduled to discuss its outlook at the Morgan Stanley 24th Annual Global Healthcare Conference on September 9, 2026.

Key facts

• Merck will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 2:15 p.m. ET with Caroline Litchfield and Dr. Dean Y. Li. source
• Institutional investors collectively own 76.07% of Merck's stock. source